false 0000765880 0000765880 2024-02-21 2024-02-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

February 21, 2024

Date of Report (Date of earliest event reported)

 

 

 

Healthpeak Properties, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 001-08895 33-0091377
(State or other jurisdiction of incorporation) (Commission File Number)

(IRS Employer Identification No.)

 

4600 South Syracuse Street, Suite 500

Denver, CO 80237

(Address of principal executive offices) (Zip Code)

 

(720) 428-5050

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     
Common Stock, $1.00 par value PEAK New York Stock Exchange

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On February 21, 2024, Healthpeak Properties, Inc. (“Healthpeak” or the “Company”) held a special meeting of stockholders (the “Special Meeting”) to consider certain proposals related to its merger with Physicians Realty Trust, a Maryland real estate investment trust (“Physicians Realty Trust”), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated October 29, 2023, by and among the Company, DOC DR Holdco, LLC (formerly known as Alpine Sub, LLC) (“DOC DR Holdco”), a Maryland limited liability company and a wholly owned subsidiary of Healthpeak, DOC DR, LLC (formerly known as Alpine OP Sub, LLC) (“DOC DR OP Sub”), a Maryland limited liability company and a wholly owned subsidiary of Healthpeak OP, LLC, Physicians Realty Trust, and Physicians Realty L.P., a Delaware limited partnership.

 

As of January 8, 2024, the record date for the Special Meeting, there were outstanding 547,157,782 shares of Healthpeak common stock, par value $1.00 per share (“Healthpeak common stock”). Three proposals were voted upon by the stockholders of Healthpeak at the Special Meeting. The voting results of those matters were as follows:

 

Proposal 1: The Healthpeak Common Stock Issuance Proposal

 

Proposal 1 (the “Healthpeak Common Stock Issuance Proposal”), to approve the issuance of Healthpeak common stock in connection with the transactions contemplated by the Merger Agreement, was approved, with the following vote counts:

             
Votes For   Votes Against   Abstentions   Broker Non-Votes
456,736,650   11,923,576   329,563  

 

Proposal 2: The Healthpeak Charter Amendment Proposal

 

Proposal 2 (the “Healthpeak Charter Amendment Proposal”), to approve an amendment to the charter of the Company to increase the authorized shares of Healthpeak common stock from a total of 750,000,000 to 1,500,000,000 shares, was approved, with the following vote counts:

             
Votes For   Votes Against   Abstentions   Broker Non-Votes
454,341,776   14,299,610   348,403  

 

Proposal 3: The Healthpeak Adjournment Proposal

 

Proposal 3, to approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Healthpeak Common Stock Issuance Proposal and/or the Healthpeak Charter Amendment Proposal if there are insufficient votes at the time of such adjournment to approve such proposals, was approved but deemed not necessary because there was a quorum present and there were sufficient proxies at the time of the Special Meeting to approve the Healthpeak Common Stock Issuance Proposal and the Healthpeak Charter Amendment Proposal.

             
Votes For   Votes Against   Abstentions   Broker Non-Votes
422,711,138   45,874,415   404,236  

 

Item 7.01 Regulation FD Disclosure.

 

On February 21, 2024, the Company and Physicians Realty Trust issued a joint press release announcing the results of their special meetings of stockholders and shareholders, respectively, related to the transactions contemplated by the Merger Agreement. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference in this Item 7.01.

 

The foregoing information in this Item 7.01, including the information contained in the press release in Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not incorporated by reference into any of the Company’s filings, whether made before or after the date hereof, regardless of any general incorporation language in any such filing.

 

 

 

Item 8.01 Other Events.

 

Based on the results of the special meetings of stockholders and shareholders of the Company and Physicians Realty Trust, respectively, the transactions contemplated by the Merger Agreement (the “Transactions”) are expected to be consummated on or around March 1, 2024, subject to the satisfaction or waiver of certain other closing conditions as described in the Merger Agreement.

 

Provided the Transactions are consummated on March 1, 2024, Healthpeak common stock is expected to begin trading under the ticker symbol “DOC” at the open of trading on The New York Stock Exchange on Monday, March 4, 2024.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)           Exhibits.

                 
Exhibit No   Description
99.1   Press release dated February 21, 2024
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: February 21, 2024 Healthpeak Properties, Inc.
   
  By: /s/ Peter A. Scott
    Peter A. Scott
    Chief Financial Officer